Quality of Life in Small-Cell Lung Cancer Patients
Author Information
Author(s): P.M. Fayers, N.M. Bleehen, D.J. Girling, R.J. Stephens
Primary Institution: Medical Research Council
Hypothesis
Does maintenance chemotherapy improve quality of life compared to no maintenance chemotherapy in small-cell lung cancer patients?
Conclusion
The study found that while chemotherapy adversely affects quality of life initially, maintenance chemotherapy may provide a palliative effect compared to no further treatment.
Supporting Evidence
- Patients allocated to no maintenance chemotherapy experienced a gradually deteriorating quality of life.
- Daily Diary Card data showed that adverse effects of chemotherapy were mostly confined to the first few days after treatment.
- Median survival was 41 weeks, with no significant difference in survival between maintenance and no maintenance groups.
Takeaway
Patients with small-cell lung cancer may feel worse right after chemotherapy, but those who continue treatment might feel better in the long run compared to those who stop.
Methodology
Patients completed a Daily Diary Card to assess their quality of life during and after treatment, with a focus on those with limited disease.
Potential Biases
Healthier patients were more likely to complete diary cards, potentially skewing results.
Limitations
Over 50% of patients returned less than half of their diary cards, which may underestimate side effects.
Participant Demographics
Patients aged 75 years or less with good performance status.
Statistical Information
P-Value
0.27
Statistical Significance
p=0.27
Want to read the original?
Access the complete publication on the publisher's website